TNO (ASX) Comparison with peers

Originally posted by 7benson7: ↑

The TNO resource itself stacks up very well with TMT and AVL, similar high grades... possibly even better in some of those pipes. With BMN nearby it's safe to assume mets will work out okay and high purity V2O5 is commercialy viable.

Massive size will eventually have a very significant voice on the world market. At the time of PFS which I'm sure management would hope to be in 2019 the NPV will be a product of the margin per pound and volume, not absolute size.

On a like for like basis you'll expect to see a similar number to the incoming AVL PFS (Dec/Jan) and TMT DFS (May/June). $2b+/-, is a reasonable figure depending on how what value you use over the mine life. Somewhat generous to AVL with it's smaller volume but they are putting much of their time and effort into post mining value adds which we could include here.

Still cheap... a much lower enterprise value per tonne of resource than next best TMT, even after dilution from the project purchase which needs to be factored in.

EV's
AVL $78m
TNO $38m
TMT $35m

I prefer the EV / assumed NPV measure as a value rating which leaves TNO very close to TMT's 1.75% and far cheaper than AVL at 3.9%. Again, you must include the purchase dilution to compare apples with apples and it takes a while to add those issues up. EV jumps from $20.8m to $37.7m once you account for those shares yet to be issued to the vendors.

So value wise TNO initially looks good but the issue is the timeline. DSO is being touted by management as a way to close the gap and generate some cashflow to get to plant construction. A great concept but we'll still need a JORC, PFS, DFS, ML, several capital raises, an offtake agreement and mine built to get there. A year or two behind the Gabba plays if it goes to plan. What's the V price doing in 2023? Not sure.

I researched and traded TNO this year and think it's got the potential to get there, but it's third in line at best and relative to TMT not priced appropriately for the time discount and V price risk. If V is still at $30 in 2021, TMT and AVL start life with monster profits not worth quoting here. TNO doesn't participate in that in all likelihood, that's the difference.

Expand

Do a little bit of research on the location of the mine. You will find out why I'm so optimistic about TNO in the long term. Who knows which one will go to production first. Investing in uranium stock I learn the grade and shallowness of the mine is very important over long term.

Of course TMT looks better in the short term since its financial position. I have no bias on these two stock since I'm holding equally and I'm sure they will move together.

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ADD

Comparison with peers, page-7

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Resolute shares bounce back as second payment made to Mali government to secure workers' release

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Comparison with peers, page-7

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Resolute shares bounce back as second payment made to Mali government to secure workers' release

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Parkes Au-Cu project to 'transform' Adavale Resources with key targets